These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Has the severity of Clostridium difficile infections increased? Das I, Jumaa P. J Hosp Infect; 2007 Jan; 65(1):85-6. PubMed ID: 17055114 [No Abstract] [Full Text] [Related]
8. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009. Roberts S, Heffernan H, Al Anbuky N, Pope C, Paviour S, Camp T, Swager T. N Z Med J; 2011 Apr 15; 124(1332):45-51. PubMed ID: 21747423 [Abstract] [Full Text] [Related]
12. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Khanna S, Pardi DS. Expert Rev Gastroenterol Hepatol; 2010 Aug 15; 4(4):409-16. PubMed ID: 20678014 [Abstract] [Full Text] [Related]
18. UK launches inquiry into Clostridium difficile outbreak. Katikireddi V. CMAJ; 2005 Jul 19; 173(2):138. PubMed ID: 16027424 [No Abstract] [Full Text] [Related]
19. [Clostridium difficile ribotype 027, toxinotype III in The Netherlands]. Kuijper EJ, Debast SB, Van Kregten E, Vaessen N, Notermans DW, van den Broek PJ. Ned Tijdschr Geneeskd; 2005 Sep 17; 149(38):2087-9. PubMed ID: 16201596 [Abstract] [Full Text] [Related]